UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061500
Receipt number R000070370
Scientific Title Exploratory study of anti-fatigue effects of tea ingestion during exercise under heat stress
Date of disclosure of the study information 2026/05/11
Last modified on 2026/05/08 20:28:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of anti-fatigue effects of tea ingestion during exercise under heat stress

Acronym

Exploratory study of anti-fatigue effects of tea ingestion during exercise under heat stress

Scientific Title

Exploratory study of anti-fatigue effects of tea ingestion during exercise under heat stress

Scientific Title:Acronym

Exploratory study of anti-fatigue effects of tea ingestion during exercise under heat stress

Region

Japan


Condition

Condition

Healthy Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the anti-fatigue effects of single dose of tea during exercise under heat stress.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in autonomic nervous system activity and salivary stress markers after recovery from fatigue.

Key secondary outcomes

Subjective fatigue sensation after recovery from fatigue.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of the test beverage.

Interventions/Control_2

Ingestion of the control beverage.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

1. Individuals who aged 20 to 39 and do not meet the exclusion criteria.
2. Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily.
3. Individuals who do not meet any of the exclusion criteria.

Key exclusion criteria

1. Individuals with a history of serious diseases of the brain, nervous system, cardiovascular system, renal failure or other severe disorders.
2. Individuals with a history of seizures (such as loss of consciousness, coma, or convulsions) due to neurological disorders.
3. Individuals who are currently under treatment or those taking prescribed medications.
4. Individuals who have difficulty performing essential evaluation items in this study due to hearing or visual impairments.
5. Individuals with food allergies.
6. Individuals who have smoked within one year prior to obtaining informed consent.
7. Individuals who consumed an average of five or more cups of tea per day within one month prior to obtaining informed consent.
8. Individuals who consumed an average of 5 or more lemons per day, or lemon-containing foods equivalent to about 5 lemons per day within one month prior to obtaining informed consent.
9. Individuals who are currently participating in another clinical trial, or who have participated in another clinical trial within one month prior to obtaining consent.
10. Individuals who cannot follow instructions for infection prevention (e.g., wearing a mask).
11. Individuals judged as inappropriate for participation by the principal investigator.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Kazunobu
Middle name
Last name Okazaki

Organization

Osaka Metropolitan University

Division name

Research Center for Urban Health and Sports

Zip code

558-8585

Address

3-3-138 Sugimoto Sumiyoshi Osaka 558-8585 JAPAN

TEL

06-6605-2950

Email

kokazaki@omu.ac.jp


Public contact

Name of contact person

1st name Kyosuke
Middle name
Last name Watanabe

Organization

Integrated Health Science Co., Ltd.

Division name

Research Division

Zip code

5300011

Address

JAM-OFFICE 5-D, JAM BASE, 5F, GRAND GREEN OSAKA North 6-38 Ofukacho, Kita-ku, Osaka, JAPAN

TEL

080-2466-6100

Homepage URL


Email

contact@integhs.jp


Sponsor or person

Institute

Osaka Metropolitan University

Institute

Department

Personal name



Funding Source

Organization

General Incorporated Association Wellness Laboratory

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Integrated Health Science Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Umekita Digital Health

Address

JAM-OFFICE 5-D, JAM BASE, 5F, GRAND GREEN OSAKA North 6-38 Ofukacho, Kita-ku, Osaka, JAPAN

Tel

080-2466-6100

Email

hrerc@integhs.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 13 Day

Date of IRB

2026 Year 04 Month 13 Day

Anticipated trial start date

2026 Year 05 Month 11 Day

Last follow-up date

2026 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 08 Day

Last modified on

2026 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070370